Hospital Based Registry of Childhood Cancer in Pediatric Oncology Units in French Speaking Africa
NCT ID: NCT03803735
Last Updated: 2025-10-03
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
10000 participants
OBSERVATIONAL
2016-01-01
2030-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Collecting the data will give much needed information on numbers, stage, treatment and outcome. The register will give data for local and national health authorities in planning pediatric cancer programs.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Therapeutic Recommendations for Nephroblastoma
NCT04423484
Impact of Tumour 1q Gain in French Pediatric and Young Adult Patients With Renal Tumours
NCT04005820
Feasability of Ambulatory Appendicectomy
NCT03186105
Evaluation of the Prevalence of E. Coli O Serotypes in Paediatric Population With Recurrent Urinary Tract Infection
NCT06482151
Does Hirschsprung Disease Increase the Risk of Febrile Urinary Tract Infection in Children
NCT04837963
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The register also collects information on vital status, treatment abandonment and loss to follow-up.
Data, collected locally is entered on line using the Research Electronic Data Capture (REDCap) program. Data are stored under the responsibility of the IT department at Gustave ROUSSY in Paris- Villejuif.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Any child with any type of cancer
3. Any child or adolescent less than 18 years of age.
Exclusion Criteria
2. Age greater than 18 years -
1 Day
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Gustave Roussy, Cancer Campus, Grand Paris
OTHER
French Africa Pediatric Oncology Group
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Brenda Mallon, MSc
Role: STUDY_DIRECTOR
French Africa Pediatric Oncology Group
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hopital Yalgado Ouedraogo
Ouagadougou, , Burkina Faso
Centre Hospitalier Universitaire Pédiatrique Charles De Gaulle
Ouagadougou, , Burkina Faso
Centre Mère et Enfant CME-FCB (Fondation Chantal Biya)
Yaoundé, , Cameroon
CHU de Treichville à ABIDJAN
Abidjan, Abidjan Autonomous District, Côte d’Ivoire
Cliniques Universitaires de Kinshasa
Kinshasa, Kinshasa City, Democratic Republic of the Congo
Cliniques Universitaires de Lubumbashi (CUL)
Lubumbashi, , Democratic Republic of the Congo
GFAOP
Villejuif, PARIS, France
l'Institut de Cancérologie de Libreville
Libreville, , Gabon
HJRA, Hôpital universitaire Joseph Ravoahangy Andrianavalona
Antananarivo, Ampefiloha, Madagascar
CHU Gabriel Touré (HGT)
Bamako, , Mali
Centre National d'Oncologie (CNO)
Nouakchott, , Mauritania
CNLC, Centre National de Lutte contre le Cancer
Niamey, , Niger
Hôpital Aristide Le Dantec, Avenue Pasteur, BP 3001
Dakar, Dakar, Senegal
CHU Sylvanus Olympio
Lomé, , Togo
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
BOUDA CHANTAL, DR
Role: primary
Sonia Ms Kaboret, Dr
Role: primary
[email protected]
Role: backup
Line Guei COUITCHERE, MD
Role: primary
BUDIONGO Aléine, DR
Role: primary
Betty NDAKISSA, DR
Role: primary
Ekhtel Benina ZEIN, DR
Role: primary
Aichatou MAHAMADOU, DR
Role: primary
Koffi Mawuse Jules GUEDENON, DR
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
GFAOP
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.